Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Prescribing Patterns With Biologics Crucial in Patients With Psoriasis

Recognition and of prescribing patterns associated with biologic medications for psoriasis is vital to understanding health care utilization and improving health systems practices for patients and providers, a new study found. Patients were classified as having psoriasis if they had 2 diagnosis codes for psoriasis, or 1 diagnosis for psoriasis and a subsequent prescription for a systemic psoriasis therapy or phototherapy on a separate day. Only patients with ≥1 prescription for a biologic medication were included. Among the findings:

  • 34,714 eligible patients were included.
  • The median time between first and last prescriptions was 3.3 - 7.0 months, depending on the drug.
  • Up to half of patients that received a prescription for a biologic medication did not receive a second prescription for the same medication.

Citation:

Noe MH, et al. Prescribing patterns associated with biologic therapies for psoriasis from a United States medical records database. J Drugs Dermatol. 2019;18(8):745-750.